Kinase modulation, and indications therefor
US9730918B2 · kind B2 · utility
22Cited by
38References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2016 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | May 5, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.